From Nasdaq: 2024-05-17 11:16:19

Financial giants are showing a bullish trend in Viking Therapeutics with 11 unusual trades observed. 45% of traders were bullish while 36% showed bearish tendencies. The trades included 2 puts valued at $78,002 and 9 calls valued at $1,174,199.

Market movers anticipate price movements between $68.0 and $130.0 for Viking Therapeutics based on trading volumes and Open Interest. Key insights into volume and open interest over the past month for calls and puts at various strike prices are crucial for stock research.

Viking Therapeutics, a healthcare company focused on biopharmaceutical development for metabolic and endocrine disorders, has clinical programs like VK2809, VK5211, and VK0214 in its pipeline. These products target specific receptors and show promise in their respective areas.

Viking Therapeutics’ current market status reveals a trading volume of 1,399,686 with a price of $68.62, down by -0.64%. The stock may be approaching overbought territory, and the next earnings report is expected in 68 days. Expert opinions on the stock vary, with target prices ranging from $90 to $120 based on recent analyst reports.

Read more at Nasdaq: Smart Money Is Betting Big In VKTX Options